A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells

Targeted Oncology

Volumn 9, Issue 2, 2014, Pages 163-170

  Lin, Nanjing ^a   Zheng, Wenyun ^b   Li, Linfeng ^a   Liu, Hui ^a   Wang, Tianwen ^a   Wang, Ping ^a   Ma, Xingyuan ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bak BH3; Cytosolic delivery; Inducing apoptosis; Tat INF7 ubiquitin (TIU) system

Indexed keywords

GLYCYLGLUTAMINYLVALYLGLYCYLARGINYLGLUTAMINYLLEUCYLALANYLISOLEUCYLISOLEUCYLGLYCYLASPARTYLASPARTYLISOLEUCYLASPARAGINYLARGININE; INF7 PEPTIDE; PEPTIDE; TRANSACTIVATOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BAX PROTEIN (53-86); HYBRID PROTEIN; ONCOPROTEIN; PEPTIDE FRAGMENT;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECRETION; RESTRICTION SITE; STOP CODON; UBIQUITINATION; DRUG EFFECTS; LUNG TUMOR; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ENDOSOMES; HUMANS; LUNG NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; UBIQUITIN;

EID: 84902548530     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-013-0282-9     Document Type: Article

References (27)

1. Talmadge JE (1998) Pharmacodynamic aspects of peptide administration biological response modifiers. Adv Drug Deliv Rev 33(3):241-252
2. Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272(25):16010-16017 (Pubitemid 27265584)
3. Chauhan A, Tikoo A, Kapur AK, Singh M (2007) The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release 117(2):148-162. doi:10.1016/j.jconrel.2006.10.031 (Pubitemid 46172502)
4. Poillot C, De Waard M (2011) Potential of cell penetrating peptides for cell drug delivery. Med Sci (Paris) 27(5):527-534. doi:10.1051/medsci/2011275019
5. Zonin E, Moscatiello R, Miuzzo M, Cavallarin N, Di Paolo ML, Sandona D, Marin O, Brini M, Negro A, Navazio L (2011) TAT-mediated aequorin transduction: an alternative approach for effective calcium measurements in plant cells. Plant Cell Physiol 52(12):2225-2235. doi:10.1093/pcp/pcr145
6. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4(12):1449-1452. doi:10.1038/4042 (Pubitemid 28553472)
7. Zhang YM, Liu CB, Liu N, Ferro Flores G, He J, Rusckowski M, Hnatowich DJ (2003) Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment. Mol Imaging Biol: MIB: Off Publ Acad Mol Imaging 5(4):240-247 (Pubitemid 37074875)
8. Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151(3):220-228. doi:10.1016/j.jconrel.2010.11.004
9. Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10(3):310-315. doi:10.1038/nm996 (Pubitemid 38667624)
10. Gump JM, Dowdy SF (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 13(10):443-448. doi:10.1016/j.molmed.2007. 08.002 (Pubitemid 47562310)
11. El-Sayed A, Futaki S, Harashima H (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J 11(1):13-22. doi:10.1208/s12248-008-9071-2
12. Cho YW, Kim JD, Park K (2003) Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol 55(6):721-734. doi:10.1211/ 002235703765951311 (Pubitemid 36752715)
13. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371(6492):37-43. doi:10.1038/371037a0 (Pubitemid 24277462)
14. Maeda T, Kawasaki K, Ohnishi S (1981) Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc Natl Acad Sci U S A 78(7):4133-4137 (Pubitemid 11010298)
15. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269(17):12918-12924 (Pubitemid 24202092)
16. Fretz MM, Mastrobattista E, Koning GA, Jiskoot W, Storm G (2005) Strategies for cytosolic delivery of liposomal macromolecules. Int J Pharm 298(2):305-309. doi:10.1016/j.ijpharm.2005.02.040 (Pubitemid 40910733)
17. Jiang X, Lok MC, Hennink WE (2007) Degradable-brushed pHEMA-pDMAEMA synthesized via ATRP and click chemistry for gene delivery. Bioconjug Chem 18(6):2077-2084. doi:10.1021/bc0701186 (Pubitemid 350220011)
18. Bachmair A, Finley D, Varshavsky A (1986) In vivo half-life of a protein is a function of its amino-terminal residue. Science 234(4773):179-186 (Pubitemid 17186094)
19. Cosulich SC, Worrall V, Hedge PJ, Green S, Clarke PR (1997) Regulation of apoptosis by BH3 domains in a cell-free system. Curr Biol 7(12):913-920 (Pubitemid 28017068)
20. Holinger EP, Chittenden T, Lutz RJ (1999) Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J Biol Chem 274(19):13298-13304
21. Shangary S, Oliver CL, Tillman TS, Cascio M, Johnson DE (2004) Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides. Mol Cancer Ther 3(11):1343-1354
22. Loison F, Nizard P, Sourisseau T, Le Goff P, Debure L, Le Drean Y, Michel D (2005) A ubiquitin-based assay for the cytosolic uptake of protein transduction domains. Mol Ther 11(2):205-214. doi:10.1016/j.ymthe.2004.10.010
23. Mann DA, Frankel AD (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 10(7):1733-1739 (Pubitemid 21905640)
24. El-Sayed A, Masuda T, Khalil I, Akita H, Harashima H (2009) Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. J Control Release 138(2):160-167. doi:10.1016/j.jconrel.2009.05.018
25. Esbjorner EK, Oglecka K, Lincoln P, Graslund A, Norden B (2007) Membrane binding of pH-sensitive influenza fusion peptides. Positioning, configuration, and induced leakage in a lipid vesicle model. Biochemistry 46(47):13490-13504. doi:10.1021/bi701075y (Pubitemid 350209946)
26. Moore NM, Sheppard CL, Barbour TR, Sakiyama-Elbert SE (2008) The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J Gene Med 10(10):1134-1149. doi:10.1002/jgm.1234
27. Borodovsky A, Kessler BM, Casagrande R, Overkleeft HS, Wilkinson KD, Ploegh HL (2001) A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 20(18):5187-5196. doi:10.1093/emboj/20.18.5187 (Pubitemid 32910913)